Literature DB >> 27154020

Plants and their active compounds: natural molecules to target angiogenesis.

Kai Lu1, Madhavi Bhat1, Sujit Basu2,3.   

Abstract

Angiogenesis, or new blood vessel formation, is an important process in the pathogenesis of several diseases and thus has been targeted for the prevention and treatment for many disorders. However, the anti-angiogenic agents that are currently in use are mainly synthetic compounds and humanized monoclonal antibodies, which are either expensive or toxic, thereby limiting their use in many patients. Therefore, it is necessary to identify less toxic, inexpensive, novel and effective anti-angiogenic molecules. Several studies have indicated that natural plant products can meet these criteria. In this review, we discuss the anti-angiogenic properties of natural compounds isolated from plants and the molecular mechanisms by which these molecules act. Finally, we summarize the advantages of using plant products as anti-angiogenic agents. Compared with currently available anti-angiogenic drugs, plant products may not only have similar therapeutic potential but are also inexpensive, less toxic, and easy to administer. However, novel and effective strategies are necessary to improve their bioavailability for clinical use.

Entities:  

Keywords:  Angiogenesis; Natural compounds; Plants; Therapy

Mesh:

Substances:

Year:  2016        PMID: 27154020      PMCID: PMC4930694          DOI: 10.1007/s10456-016-9512-y

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  90 in total

1.  Anti-allergic activity of some selected plants in the Zingiberaceae family.

Authors:  Supinya Tewtrakul; Sanan Subhadhirasakul
Journal:  J Ethnopharmacol       Date:  2006-08-15       Impact factor: 4.360

2.  Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo.

Authors:  MaLing Gou; Ke Men; HuaShan Shi; MingLi Xiang; Juan Zhang; Jia Song; JianLin Long; Yang Wan; Feng Luo; Xia Zhao; ZhiYong Qian
Journal:  Nanoscale       Date:  2011-01-31       Impact factor: 7.790

Review 3.  Therapeutic perspectives in vascular remodeling in asthma and chronic obstructive pulmonary disease.

Authors:  Dario Olivieri; Alfredo Chetta
Journal:  Chem Immunol Allergy       Date:  2013-10-17

Review 4.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

5.  Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells.

Authors:  Maryam R Sartippour; Zhi-Ming Shao; David Heber; Perrin Beatty; Liping Zhang; Canhui Liu; Lee Ellis; Wen Liu; Vay Liang Go; Mai N Brooks
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

Review 6.  Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.

Authors:  Ornchuma Naksuriya; Siriporn Okonogi; Raymond M Schiffelers; Wim E Hennink
Journal:  Biomaterials       Date:  2014-01-15       Impact factor: 12.479

7.  Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors.

Authors:  A Craig Lockhart; Mace L Rothenberg; Jakob Dupont; Wendy Cooper; Paul Chevalier; Lars Sternas; Giliane Buzenet; Elizabeth Koehler; Jeffrey A Sosman; Lawrence H Schwartz; David H Gultekin; Jason A Koutcher; Edwin F Donnelly; Ric Andal; Isabelle Dancy; David R Spriggs; William P Tew
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544

8.  Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.

Authors:  Imtiaz A Siddiqui; Vaqar M Adhami; Dhruba J Bharali; Bilal B Hafeez; Mohammad Asim; Sabih I Khwaja; Nihal Ahmad; Huadong Cui; Shaker A Mousa; Hasan Mukhtar
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

9.  Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2.

Authors:  K Sato; M Mochizuki; I Saiki; Y C Yoo; K Samukawa; I Azuma
Journal:  Biol Pharm Bull       Date:  1994-05       Impact factor: 2.233

10.  trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.

Authors:  Zongxian Cao; Jing Fang; Chang Xia; Xianglin Shi; Bing-Hua Jiang
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

View more
  13 in total

Review 1.  Consensus guidelines for the use and interpretation of angiogenesis assays.

Authors:  Patrycja Nowak-Sliwinska; Kari Alitalo; Elizabeth Allen; Andrey Anisimov; Alfred C Aplin; Robert Auerbach; Hellmut G Augustin; David O Bates; Judy R van Beijnum; R Hugh F Bender; Gabriele Bergers; Andreas Bikfalvi; Joyce Bischoff; Barbara C Böck; Peter C Brooks; Federico Bussolino; Bertan Cakir; Peter Carmeliet; Daniel Castranova; Anca M Cimpean; Ondine Cleaver; George Coukos; George E Davis; Michele De Palma; Anna Dimberg; Ruud P M Dings; Valentin Djonov; Andrew C Dudley; Neil P Dufton; Sarah-Maria Fendt; Napoleone Ferrara; Marcus Fruttiger; Dai Fukumura; Bart Ghesquière; Yan Gong; Robert J Griffin; Adrian L Harris; Christopher C W Hughes; Nan W Hultgren; M Luisa Iruela-Arispe; Melita Irving; Rakesh K Jain; Raghu Kalluri; Joanna Kalucka; Robert S Kerbel; Jan Kitajewski; Ingeborg Klaassen; Hynda K Kleinmann; Pieter Koolwijk; Elisabeth Kuczynski; Brenda R Kwak; Koen Marien; Juan M Melero-Martin; Lance L Munn; Roberto F Nicosia; Agnes Noel; Jussi Nurro; Anna-Karin Olsson; Tatiana V Petrova; Kristian Pietras; Roberto Pili; Jeffrey W Pollard; Mark J Post; Paul H A Quax; Gabriel A Rabinovich; Marius Raica; Anna M Randi; Domenico Ribatti; Curzio Ruegg; Reinier O Schlingemann; Stefan Schulte-Merker; Lois E H Smith; Jonathan W Song; Steven A Stacker; Jimmy Stalin; Amber N Stratman; Maureen Van de Velde; Victor W M van Hinsbergh; Peter B Vermeulen; Johannes Waltenberger; Brant M Weinstein; Hong Xin; Bahar Yetkin-Arik; Seppo Yla-Herttuala; Mervin C Yoder; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2018-08       Impact factor: 9.596

2.  Antiangiogenic effects of oridonin.

Authors:  Lili Tian; Kangjie Xie; Donglai Sheng; Xiaoqing Wan; Guofu Zhu
Journal:  BMC Complement Altern Med       Date:  2017-04-04       Impact factor: 3.659

3.  Aspalatone Prevents VEGF-Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial Cells.

Authors:  Himangshu Sonowal; Pabitra B Pal; Kirtikar Shukla; Kota V Ramana
Journal:  Oxid Med Cell Longev       Date:  2017-01-24       Impact factor: 6.543

Review 4.  Use of animal models for the imaging and quantification of angiogenesis.

Authors:  Min Liu; Songbo Xie; Jun Zhou
Journal:  Exp Anim       Date:  2017-07-31

Review 5.  Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.

Authors:  Khalid El Bairi; Mariam Amrani; Said Afqir
Journal:  Cancer Med       Date:  2018-05-06       Impact factor: 4.452

6.  Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.

Authors:  Gengyi Zou; Xiaotong Zhang; Lun Wang; Xiyang Li; Tianyu Xie; Jin Zhao; Jie Yan; Longlong Wang; Haoyu Ye; Shunchang Jiao; Rong Xiang; Yi Shi
Journal:  Theranostics       Date:  2020-05-22       Impact factor: 11.556

Review 7.  Antiangiogenic Targets for Glioblastoma Therapy from a Pre-Clinical Approach, Using Nanoformulations.

Authors:  Gabriel Nery de Albuquerque Rego; Arielly da Hora Alves; Mariana Penteado Nucci; Javier Bustamante Mamani; Fernando Anselmo de Oliveira; Lionel Fernel Gamarra
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

8.  Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts.

Authors:  Harsha Raj M; Debidas Ghosh; Rita Banerjee; Bharathi P Salimath
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 9.  Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms.

Authors:  Weilin Zheng; Lixing Cao; Zheng Xu; Yuanyuan Ma; Xuefang Liang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-01       Impact factor: 2.629

10.  Vialinin A, an Edible Mushroom-Derived p-Terphenyl Antioxidant, Prevents VEGF-Induced Neovascularization In Vitro and In Vivo.

Authors:  Himangshu Sonowal; Kirtikar Shukla; Sumedha Kota; Ashish Saxena; Kota V Ramana
Journal:  Oxid Med Cell Longev       Date:  2018-02-06       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.